Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

A research team has developed an AI-based personalized cancer vaccine design technology that enables long-term immunity that ...

KAIST Professor Jung Kyoon Choi, Dr. Jeong Yeon Kim, and Dr. Jin Hyeon An >Neoantigens are unique markers that distinguish only cancer ...

The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...

And the danger doesn’t end once your measles symptoms subside. Research shows that even after recovery, your immune system ...

Researchers found that in mouse models (in a lab), SARS‑CoV‑2 mRNA vaccination triggered strong type I interferon signals, ...

The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...

A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm ...

A joint research team from the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model designed to ...

KAIST and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model to produce a new type of personalised cancer vaccine ...

Silica nanomaterial cuts immunotherapy costs while boosting cancer treatment efficacy by nearly 70% in animal studies.